Cargando…
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs
Neuroblastoma (NB) is one of the most frequently occurring neurogenic extracranial solid cancers in childhood and infancy. Over the years, many pieces of evidence suggested that NB development is controlled by gene expression dysregulation. These unleashed programs that outline NB cancer cells make...
Autores principales: | Ciaccio, Roberto, De Rosa, Piergiuseppe, Aloisi, Sara, Viggiano, Marta, Cimadom, Leonardo, Zadran, Suleman Khan, Perini, Giovanni, Milazzo, Giorgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657550/ https://www.ncbi.nlm.nih.gov/pubmed/34884690 http://dx.doi.org/10.3390/ijms222312883 |
Ejemplares similares
-
MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells
por: De Rosa, Piergiuseppe, et al.
Publicado: (2023) -
AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988) -
Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989) -
Single-Cell Sequencing Identifies Master Regulators Affected by Panobinostat in Neuroblastoma Cells
por: Milazzo, Giorgio, et al.
Publicado: (2022) -
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
por: Milazzo, Giorgio, et al.
Publicado: (2020)